Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLDEB for Herpes Simplex Epithelial Keratitis
NCT03217474Unknown
- Start
- Jul 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in Herpes simplex keratitis. Primary endpoint: Healing time at 2 weeks. Status: unknown.
02
Conditions
Herpes simplex keratitis
Beyond the preview
Go deeper on NCT03217474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03217474.